Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$4 6146
2025
Q4
$4 Sell
1
-305
-100% -$1.3K ﹤0.01% 5877
2025
Q3
$1.57K Sell
306
-582
-66% -$3.89K ﹤0.01% 5541
2025
Q2
$9.26K Buy
+888
New +$12.1K ﹤0.01% 5201
2025
Q1
Sell
-100
Closed -$1.23K 5760
2024
Q4
$1.23K Buy
+100
New +$1.16K ﹤0.01% 5582
2024
Q2
Sell
-4
Closed -$75 5677
2024
Q1
$75 Buy
+4
New +$38 ﹤0.01% 5505
2023
Q1
Sell
-23
Closed -$406 5671
2022
Q4
$406 Buy
+23
New +$442 ﹤0.01% 5532
2022
Q3
Sell
-858
Closed -$20K 6062
2022
Q2
$20K Buy
+858
New +$31.4K ﹤0.01% 5002
2020
Q3
Sell
-9
Closed -$6K 7516
2020
Q2
$6K Buy
+9
New +$3.9K ﹤0.01% 7217
2016
Q2
Sell
-1
Closed -$2K 7215
2016
Q1
$2K Buy
+1
New +$3.8K ﹤0.01% 7205
2015
Q4
Hold
0
7689
2015
Q3
Hold
0
7169
2015
Q2
Sell
-1
Closed -$7.1K 7128
2015
Q1
$8K Hold
1
﹤0.01% 6544
2014
Q4
$8K Hold
1
﹤0.01% 6545
2014
Q3
$10K Hold
1
﹤0.01% 6272
2014
Q2
$10K Hold
1
﹤0.01% 6170
2014
Q1
$10K Hold
1
﹤0.01% 6337
2013
Q4
$13K Hold
1
﹤0.01% 6336
2013
Q3
$16K Hold
1
﹤0.01% 6019
2013
Q2
$13K Buy
+1
New +$13.9K ﹤0.01% 5995

Other funds holding IMNN

Citigroup's IMNN Position: Q1 2026 in Review

Citigroup sold out of Imunon (IMNN) in Q1 2026, closing a stake of 1 share — an estimated $4 sold.

Citigroup first reported a position in IMNN in Q2 2013 and held it in 17 quarters. The position peaked at $20K in Q2 2022. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

  • Citigroup reported no remaining Imunon position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 Imunon share in Q1 2026, an estimated $4.
  • Citigroup first reported a position in Imunon in Q2 2013 and held it in 17 quarters.
  • Citigroup's Imunon position peaked at $20K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.